Abbott Laboratories vs ViroGates A/S
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Abbott Laboratories is the larger company by market value: $181.1 B against $6 M for ViroGates A/S, 30185 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 5, 2024 for ViroGates A/S). ViroGates A/S's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Abbott Laboratories ABT · #117 in the world | ViroGates A/S VIRO.CO |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇩🇰 Denmark |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Founded | 1888 | — |
| Size | ||
| Market cap | $181.1 B | $6 M* |
| Revenue | $44.3 B | — |
| Net income | $6.5 B | — |
| Employees | 115,000 | — |
| Valuation | ||
| P/E ratio | 38.5× | — |
| Price to sales | 3.8× | — |
| Price to book | 3.5× | — |
| Free cash flow yield | 4.1% | — |
| Profitability | ||
| Gross margin | 56.4% | — |
| Operating margin | 18.2% | — |
| Net margin | 14.7% | — |
| Return on equity | 13.1% | — |
| Return on invested capital | 11.2% | — |
| Growth | ||
| Revenue growth | 5.7% | — |
| Revenue growth, 3 years a year | 0.5% | — |
| Earnings per share growth | -51.3% | — |
| Financial strength | ||
| Debt to equity | 0.3× | — |
| Cash | ||
| Free cash flow margin | 16.7% | — |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.8% | — |
| Strength scores | ||
| Piotroski F-score | 6 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Abbott Laboratories or ViroGates A/S?
Abbott Laboratories is the larger company by market value: $181.1 B against $6 M for ViroGates A/S, 30185 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 5, 2024 for ViroGates A/S). ViroGates A/S's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
More about Abbott Laboratories
More about ViroGates A/S
Sources#
Every figure on this page comes from these, with the date shown next to it.